Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥696,000 | ¥691,000 | ¥309,000 | ¥290,000 |
| Dep. & Amort. | ¥0 | ¥0 | ¥0 | ¥1,051,500 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥0 | ¥0 | ¥0 | ¥1,588,500 |
| Other Non-Cash | -¥696,000 | -¥691,000 | -¥309,000 | -¥2,010,000 |
| Operating Cash Flow | ¥0 | ¥0 | ¥0 | ¥920,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | ¥0 | ¥0 | ¥0 | -¥2,444,000 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Inv. Act. | ¥0 | ¥0 | ¥0 | -¥199,500 |
| Investing Cash Flow | ¥0 | ¥0 | ¥0 | -¥2,643,500 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | -¥232,000 |
| Other Fin. Act. | ¥0 | ¥0 | ¥0 | ¥2,214,000 |
| Financing Cash Flow | ¥0 | ¥0 | ¥0 | ¥1,982,000 |
| Forex Effect | ¥0 | ¥0 | ¥0 | -¥1,500 |
| Net Chg. in Cash | ¥0 | ¥0 | ¥0 | ¥0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥0 | ¥0 | ¥0 | ¥0 |
| End Cash | ¥0 | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | ¥0 | ¥0 | ¥0 | -¥1,524,000 |